{"certainAgreement":{"piSponsorEmployee":true},"limitationsAndCaveats":{"description":"We did not meet criteria to stop the study because of nonrelapse mortality (safety endpoint). However, we stopped accrual to the study because of failure to meet minimal criteria for engraftment (efficacy endpoint)."},"pointOfContact":{"email":"ayeager@azcc.arizona.edu","organization":"University of Arizona, Arizona Cancer Center","phone":"520-626-0662","title":"Andrew M. Yeager, MD"}}